![](https://financialmodelingprep.com/image-stock/ACRS.png)
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
$83.47M
Dr. Douglas J. Manion Frcp(C), M.D.
72.00
Wayne, PA
Oct 07, 2015
-1.43
$-0.82
1.46
7.50
-183.28%
-1.43
-0.04
0.63
2.63
7.50
-36.43%
-39.83%
Similar stocks (8)
IQVIA Holdings Inc.
IQV
Medpace Holdings, Inc.
MEDP
RadNet, Inc.
RDNT
Sotera Health Company
SHC
Neogen Corporation
NEOG
Myriad Genetics, Inc.
MYGN
Castle Biosciences, Inc.
CSTL
Biodesix, Inc.
BDSX
ETF Exposure (18)
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.05%
iShares Micro-Cap ETF
IWC
0.0218%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.008%
iShares Biotechnology ETF
IBB
0.00798%
ProShares Ultra Nasdaq Biotechnology
BIB
0.002425484380792945%
Schwab U.S. Small-Cap ETF
SCHA
0.0017794971%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (8)
IQVIA Holdings Inc.
IQV
Medpace Holdings, Inc.
MEDP
RadNet, Inc.
RDNT
Sotera Health Company
SHC
Neogen Corporation
NEOG
Myriad Genetics, Inc.
MYGN
Castle Biosciences, Inc.
CSTL
Biodesix, Inc.
BDSX
ETF Exposure (18)
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.05%
iShares Micro-Cap ETF
IWC
0.0218%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.008%
iShares Biotechnology ETF
IBB
0.00798%
ProShares Ultra Nasdaq Biotechnology
BIB
0.002425484380792945%
Schwab U.S. Small-Cap ETF
SCHA
0.0017794971%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%